Artio Medical
Prairie Village, US
Biotech
Founders & leadership
MN
Maria Nicholas SainzDirector
JM
James M. SchultzDirector
NN
Nathaniel Nicholas HagedornDirector
JM
John M. AyresExecutive Officer
AN
Abhinav Nicholas ShuklaDirector
FN
Frank Nicholas FrananoExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$5.1MraisedDec 2022 · 13 investors · Biotechnology
Rule 506(b)$16.3MraisedJul 2022 · 90 investors · Biotechnology
Rule 506(b)$11.4MraisedFeb 2022 · 58 investors · Biotechnology
Rule 506(b)$7MraisedAug 2021 · 56 investors · Biotechnology
Rule 506(b)$5MraisedFeb 2021 · 68 investors · Biotechnology
Rule 506(b)$402.2KraisedOct 2020 · 8 investors · Biotechnology
Rule 506(b)Undisclosed amountofferedOct 2020 · Biotechnology
Rule 506(b)$17.5MraisedOct 2020 · 132 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.